ARCHIVES

NCI Needs $107 Million More In FY 1982 Than Asked for Key Programs, R01s And P01s, New Initiatives

This article is from The Cancer Letter archive.

Vol. 07 No. 16 | April 17, 1981

Download PDF Visit The Full Archive

Related Articles

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013

NCI Must Limit Grant Payments for Now, Until Congress Approves FY03 Budget

December 6, 2002

AACR Honors Nine Cancer Researchers, Clinicians.

March 31, 2000

In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control

October 31, 1997

NIH Review Division Considering Proposal For Clinical Oncology Study Section

October 10, 1997